Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00039130 Information provided by Cancer and Leukemia Group B

First Received: June 6, 2002 Last Updated: June 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2019
Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)